Implementing medical abortion through telemedicine in Colombia: a qualitative study.
Colombia
acceptability
feasibility
healthcare provider
implementation science
medical abortion
service delivery
telemedicine
Journal
Sexual and reproductive health matters
ISSN: 2641-0397
Titre abrégé: Sex Reprod Health Matters
Pays: England
ID NLM: 101743493
Informations de publication
Date de publication:
Dec 2023
Dec 2023
Historique:
medline:
14
8
2023
pubmed:
11
8
2023
entrez:
11
8
2023
Statut:
ppublish
Résumé
The non-governmental organisation Profamilia developed and implemented medical abortion through telemedicine in response to the Covid-19 pandemic. This service is now integrated as an alternative to in-person care and available to abortion-seekers across Colombia. Previous research has emphasised bottlenecks in abortion provision, but less is known about implementation processes and experiences. We assessed the feasibility and acceptability of telemedicine for medical abortion from the perspectives of key informants involved in the implementation in Colombia. We conducted 15 in-depth interviews with healthcare professionals, coordinators and support staff implementing telemedicine for medical abortion in the early phase of implementation, between March and October 2021. We analysed the data using the framework method and applied the normalisation process theory in our analysis and interpretation of findings. Our findings show that strong leadership, organisational efforts on pre-implementation training, monitoring and evaluation, and collaboration between diversely skilled and experienced providers are essential for successful implementation. Participants were generally positive towards the use of telemedicine for medical abortion; concerns related to effectiveness, safety and safeguarding existed mainly among providers with less clinical experience. We identified contextual barriers, such as social opposition, regulatory barriers, providers' unavailability, and poor phone and internet connections in rural areas, which impacted the feasibility of the intervention negatively. In conclusion, to ensure stakeholders' buy-in and for the service to reach all abortion seekers in need, future implementation endeavours must address concerns about safety and effectiveness, and tackle identified contexual barriers.
Identifiants
pubmed: 37565788
doi: 10.1080/26410397.2023.2236780
pmc: PMC10424593
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
2236780Références
Gac Sanit. 2015 May-Jun;29(3):198-204
pubmed: 25770915
Sex Reprod Health Matters. 2022;29(3):2034366
pubmed: 35192443
BJOG. 2019 Aug;126(9):1094-1102
pubmed: 30869829
BMC Med Res Methodol. 2013 Sep 18;13:117
pubmed: 24047204
Implement Sci. 2014 Jan 02;9:2
pubmed: 24383661
Sex Reprod Health Matters. 2021 Dec;29(1):1921901
pubmed: 33982638
BJOG. 2019 Apr;126(5):609-618
pubmed: 30456778
Reprod Health. 2023 Apr 13;20(1):61
pubmed: 37055839
BMJ. 2017 Mar 6;356:i6795
pubmed: 28264797
Best Pract Res Clin Obstet Gynaecol. 2020 Feb;63:74-86
pubmed: 31383555
BJOG. 2021 Aug;128(9):1464-1474
pubmed: 33605016
Lancet. 2022 Aug 27;400(10353):670-679
pubmed: 36030811
Implement Sci. 2009 May 21;4:29
pubmed: 19460163
BMJ Sex Reprod Health. 2021 Oct;47(4):e14
pubmed: 33093040
Qual Health Res. 2022 Apr;32(5):788-799
pubmed: 35322703
BMJ Glob Health. 2022 Oct;7(10):
pubmed: 36202429
World Med Health Policy. 2016 Dec;8(4):382-408
pubmed: 28503353
Contraception. 2021 Jul;104(1):82-91
pubmed: 33932401
BMJ Sex Reprod Health. 2022 Jul;48(3):199-204
pubmed: 34848554
Acta Obstet Gynecol Scand. 2021 Apr;100(4):571-578
pubmed: 33179265
Int J Qual Health Care. 2007 Dec;19(6):349-57
pubmed: 17872937
Front Glob Womens Health. 2022 Aug 01;3:898754
pubmed: 35979197
Adm Policy Ment Health. 2011 Mar;38(2):65-76
pubmed: 20957426
Qual Quant. 2018;52(4):1893-1907
pubmed: 29937585
Contraception. 2022 Oct;114:67-73
pubmed: 35753406
Lancet. 2021 Aug 7;398(10299):555-558
pubmed: 34364526
Mhealth. 2022 Oct 30;8:32
pubmed: 36338311
Best Pract Res Clin Obstet Gynaecol. 2020 Feb;63:87-110
pubmed: 31859163
Int J Gynaecol Obstet. 2018 Oct;143 Suppl 4:12-18
pubmed: 30374985
BMJ Sex Reprod Health. 2020 Oct;46(4):241-243
pubmed: 32788180
Lancet. 2022 Feb 26;399(10327):803-813
pubmed: 35182472